Appendix C. List of organisations involved in this appraisal
The following organisations are consultees/commentators in this appraisal. Consultees are also invited to appeal against the Final Appraisal Determination.
I) Professional/specialist and patient/carer groups:
-
Association of Cancer Physicians
-
Association of Surgeons of Great Britain and Ireland
-
British Association of Surgical Oncology
-
British Oncological Association
-
British Oncology Pharmacy Association (BOPA)
-
British Psychosocial Oncology Society (BPOS)
-
Cancer Research UK
-
Community Practitioners' & Health Visitors' Association
-
Medical Women's Federation
-
Royal of General Practitioners
-
Royal College
-
Royal of Pathologists
-
Royal of Physicians' Medical Oncology Joint Special Committee
-
Royal of Radiologists
-
Royal of Surgeons
-
Royal Pharmaceutical Society
-
Breakthrough Breast Cancer
-
Breast Cancer Campaign
-
Breast Cancer Care
-
Cancer Voices
-
Cancerbackup
-
Long-term Medical Conditions Alliance
-
Macmillan Cancer Relief
-
Marie Curie Cancer Care
-
National Cancer Alliance
-
National Council for Palliative Care
-
Tenovus Cancer Information Centre
II) Commentator organisations (without the right of appeal):
-
Board of Community Health Councils in Wales
-
British National Formulary
-
Medicines and Healthcare products Regulatory Agency (MHRA)
-
National Public Health Service for Wales
-
NHS Confederation
-
NHS Purchasing and Supplies Agency
-
NHS Quality Improvement Scotland
-
Baxter Healthcare Ltd
-
Bayer plc
-
Bristol-Myers Squibb Pharmaceuticals Ltd
-
Genus Pharmaceuticals
-
GlaxoSmithKline
-
Goldshield Pharmaceuticals Ltd
-
Kyowa Hakko UK Ltd
-
Mayne Pharma plc
-
Medac UK
-
Pfizer Ltd [Pharmacia]
-
Pierre Fabre Ltd
-
Roche Products Ltd
-
Sanofi-Aventis
-
Schering-Plough Ltd
-
Wyeth Pharmaceuticals
-
Cochrane Collaboration – Cochrane Breast Cancer Group
-
Institute Research
-
MRC Clinical Trials Unit
-
National Cancer Research Institute
-
National Coordinating Centre for Health Technology Assessment
-
Southampton Health Technology Assessment Centre
-
National Collaborating Centre for Cancer